UTGIVER AV

 

Utgave for helsepersonell

ambulanse.jpg

Illustrasjonsfoto

Les mer om hva du bør og ikke bør gjøre, for å hjelpe en person med epilepsianfall.

  • Sist endret: 04.08.2015
  • Sist revidert: 04.08.2015

Vil du vite mer?

Dette dokumentet er basert på det profesjonelle dokumentet "Epilepsi" i Norsk Elektronisk Legehåndbok. Referanselisten for dette dokumentet vises nedenfor.

Referanser

  1. Gjerstad L, Taubøll E. Hva er epilepsi?. Tidsskr Nor Lægeforen 2003; 123: 1359-61. Tidsskriftet
  2. Duncan JS, Sander JW, Sisodiya SM, Walker MC. Adult epilepsy. Lancet 2006; 367: 1087-100. PubMed
  3. Marson A, Maguire M, Ramaratnam S. Epilepsy. Clinical Evidence, June 2009.
  4. Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003; 16: 165-70. PubMed
  5. Forsgren L, Beghi E, Oun A, et al. The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol 2005; 12: 245-53. PubMed
  6. Gjerstad L, Taubøll E. Epilepsi og genetikk. Tidsskr Nor Lægeforen 2003; 123: 2731-4. Tidsskriftet
  7. Christensen J, Pedersen MG, Pedersen CB, et al. Long-term risk of epilepsy after traumatic brain injury in children and young adults: a population-based cohort study. Lancet 2009; 338: e-pub.
  8. Fisher RS, van Emde BW, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005; 46: 470-72. PubMed
  9. Litt B and Echauz J. Prediction of epileptic seizures. Lancet Neurol 2002; 1: 22-30. PubMed
  10. Karlsen B, Engelsen B. Ikke-konvulsiv status epilepticus - anfallsvis konfusjon og kognitiv svikt. Tidsskr Nor Lægeforen 2000; 120: 3526-9. Tidsskriftet
  11. Blümcke I. Neuropathology of focal epilepsies: a critical review. Epilepsy Behav 2009; 15: 34. PubMed
  12. Christensen J, Pedersen MG, Pedersen CB, et al. Long term risk of epilepsy after traumatic brain injury in children and young adults: a population based cohort study. Lancet 2009; Mar 28;373(9669):1105-10. doi: 10.1016/S0140-6736(09)60214-2. DOI
  13. Heaney DC, MacDonald BK, Everitt A, Stevenson S, Leonardi GS, Wilkinson P et al. Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England. BMJ 2002; 325: 1013 - 6. BMJ
  14. Erdal J, Høgenhaven H. Faldgruber ved epilepsidiagnostik. Ugeskr Læger 2004; 166: 3915-8. Ugeskrift
  15. Scheepers B, Clough P, Pickles C. The misdiagnosis of epilepsy: findings of a population study. Seizure 1998; 7: 403-6. PubMed
  16. Management of treatment-resistant epilepsy. Evid Rep Technol Assess 2003: 153-8.
  17. Haver B. Fra syk lege til vanskelig pasient. Tidsskr Nor Lægeforen 2004; 124: 373-5. Tidsskriftet
  18. Benbadis SR. Localization-related (partial) epilepsy: Causes and clinical features. UpToDate, last updated Oct 17, 2011. UpToDate
  19. Tuchscherer V, Seidenberg M, Pulsipher D, Lancaster M, Guidotti L, Hermann B. Extrahippocampal integrity in temporal lobe epilepsy and cognition: thalamus and executive functioning. Epilepsy Behav 2010; 17: 478. PubMed
  20. Riley JD, Franklin DL, Choi V, Kim RC, Binder DK, Cramer SC, Lin JJ. Altered white matter integrity in temporal lobe epilepsy: association with cognitive and clinical profiles. Epilepsia 2010; 51: 536. PubMed
  21. Zaidi A, Clough P, Cooper P, et al. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol 2000; 36; 181-4.
  22. Rugg-Gunn FJ, Eriksson SH, Symms MR et al. Diffusion tensor imaging of cryptogenic and acquired partial epilepsies. Brain 2001;124:627-36. PubMed
  23. Wesenberg Kjær T, Christensen T. Billeddiagnostiske undersøgelser ved epilepsi. Ugeskr Læger 2004; 166: 3912-5. Ugeskrift
  24. Kammerman S, Wasserman L. Seizure disorders. Classification and diagnosis. West J Med 2001; 175: 99-103. PubMed
  25. Duncan JS. Neuroimaging for epilepsy: quality and not just quantity is important. J Neurol Neurosurg Psychiatry 2002; 73: 612-3. PubMed
  26. Sander JW. The use of antiepileptic drugs - principles and practice. Epilepsia 2004; 45 (suppl 6); 28-34.
  27. Gjerstad L, Taubøll E, Røste GK. Behandling av epilepsi. Tidsskr Nor Lægeforen 2003; 123: 1864-8. Tidsskriftet
  28. Sander JW and Bell GS. Reducing mortality: an important aim of epilepsy management. J Neurol Neurosurg Psychiatry 2004; 75: 349-51. PubMed
  29. Birbeck GL, Hays RD, Cui X, et al. Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 2002; 43: 535-8. PubMed
  30. Nakken KO. Bør personer med epilepsi drive fysisk aktivitet?. Tidsskr Nor Lægeforen 2000; 120: 3051-3. Tidsskriftet
  31. Nakken KO. Physical exercise in outpatients with epilepsy. Epilepsia 1999; 40: 643-51. PubMed
  32. Krumholz A, Wiebe S, Gronseth GH, et al. Evidence-based guideline: Management of an unprovoked first seizure in adults. Neurology 2015; 84: 1705-13. doi:10.1212/WNL.0000000000001487 DOI
  33. Hauser WA, Rich SS, Lee JR, Annegers JF, Anderson VE. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 1998; 12: 429 - 34. NEJM
  34. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006; 47: 1094-120. PubMed
  35. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369:1000-15. PubMed
  36. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997; 38: 859-80. PubMed
  37. PRAC recommends strengthening the restrictions on the use of valproate in women and girls. European Medicines Agency. 10/10/2014 http://www.ema.europa.eu/ema/index.jsp?curl=p...
  38. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1016-26. PubMed
  39. Bråthen G. Alkohol og epilepsi. Tidsskr Nor Lægeforen 2003; 123: 1536-8. Tidsskriftet
  40. Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 2005; 365: 2007-13. PubMed
  41. Strozzi I, Nolan SJ, Sperling MR, Wingerchuk DM, Sirven J. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database of Systematic Reviews 2015, Issue 2. Art. No.: CD001902. DOI: 10.1002/14651858.CD001902.pub2. DOI
  42. Berg AT, Shinnar S. Relapse following discontinuation of antiepileptic drugs. Neurology 1994; 44: 601-8. Neurology
  43. Bjellvi J, Flink R, Rydenhag B, et al. Complications of epilepsy surgery in Sweden 1996-2010: a prospective, population-based study. J Neurosurg. 2014 :1-7. PMID: 25361484. PubMed
  44. Panebianco M, Rigby A, Weston J, Marson AG. Vagus nerve stimulation for partial seizures. Cochrane Database of Systematic Reviews 2015, Issue 4. Art. No.: CD002896. DOI: 10.1002/14651858.CD002896.pub2. DOI
  45. Nakken KO, Henriksen O, Røste GK, Lossius R. Kronisk intermitterende stimulering av nervus vagus - en ny behandlingsform ved epilepsi. Tidsskr Nor Lægeforen 2001; 121: 1582-5. Tidsskriftet
  46. DeGiorgio CM, Soss J, Cook IA, et al. Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology 2013 Feb 26;80(9):786-91. doi:10.1212/WNL.0b013e318285c11a. DOI
  47. Rytter E, Johannessen SI, Nakken KO. Medikamentell antikonsepsjon hos kvinner med epilepsi. Tidsskr Nor Lægeforen 2003; 123: 1674-5. Tidsskriftet
  48. Cheuk DK, Wong V. Acupuncture for epilepsy. Cochrane Database Syst Rev. 2014 May 7;5:CD005062. Cochrane
  49. Nakken KO, Brodtkorb E, Koht J. Epilepsi og rehabilitering. Tidsskr Nor Lægeforen 2007; 127: 309-12. Tidsskriftet
  50. Kvan E, Narum S. P-piller med forlenget syklus - et fremskritt?. Tidsskr Nor Lægeforen 2005; 125: 2202-3. Tidsskriftet
  51. Couldridge L, Kendall S, March A. A systemativ overview - a decade of research. The indormation and councelling needs of people with epilepsy. Seizure 2001; 10: 605-14. PubMed
  52. Smed A, Sahlholdt L, Olesen P. Psykosociale konsekvenser af epilepsi. Ugeskr Læger 2004; 166: 3922-4. Ugeskrift
  53. Nakken KO, Taubøll E. Bone loss associated with use of antiepileptic drugs. Expert Opin Drug Saf 2010; 9: 561-71. PubMed
  54. Taubøll E, Gjerstad L, Henriksen T, Husby H. Svangerskap og fødsel hos kvinner med epilepsi. Tidsskr Nor Lægeforen 2003; 123: 1695-7. Tidsskriftet
  55. Breen DP. Teratogenicity of antiepileptic drugs. BMJ 2006; 333: 615-6. BMJ
  56. Adab N, Tudur Smith C, Vinten J, Williamson PR, Winterbottom JB. Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD004848. DOI: 10.1002/14651858.CD004848. DOI
  57. Morrow JI, Russell A, Gutherie E, Parsons L, Robertson I, Waddell R, et al. Malformation risks of anti-epileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006; 77: 193-8. PubMed
  58. Nadebaum C, Anderson VA, Vajda F, et.al. Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology 2011; 76: 719-26. Neurology
  59. Lossius R, Nakken KO. Epilepsi og plutselig død. Tidsskr Nor Lægeforen 2002; 122: 1114-7. Tidsskriftet
  60. Wolf P. Aktuelle problemer i epilepsibehandlingen. Ugeskr Læger 2004; 166: 3907. Ugeskrift
  61. Christensen J, Vestergaard M, Mortensen PB, Sidenius P, Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 2007; 6: 693-8. PubMed
  62. Pilebæk Hansen C, Alving J . Status epilepticus. Ugeskr Læger 2004; 166: 3918-22. Ugeskrift
  63. Erdal J, Sabers A. Fertilitet, kontraception og graviditet hos patienter med epilepsi. Ugeskr Læger 2004; 166: 3925-9. Ugeskrift
  64. Nakken KO, Lillestølen KM, Taubøll E, Engelsen B, Brodtkorb E. Epilepsi og svangerskap - medikamentbruk, anfallskontroll og komplikasjoner. Tidsskr Nor Lægeforen 2006; 126: 2507-10. Tidsskriftet
  65. Bjørk MH, Veiby G, Reiter SC, et al. Depression and anxiety in women with epilepsy during pregnancy and after delivery: A prospective population-based cohort study on frequency, risk factors, medication, and prognosis. Epilepsia 2015; 56: 28-39. doi:10.1111/epi.12884 DOI
  66. Wiebe S. An evidence based approach to the first unprovoked seizure. Can J Neurol Sci 2002; 29: 120-4. PubMed
  67. Lhatoo SD, Johnson AL, Goodridge DM, et al. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 2001; 49: 336-44. PubMed
  68. Gaitatzis A, Johnson AL, Chadwick DW, et al. Life expectancy in people with newly diagnosed epilepsy. Brain 2004; 127: 2427-32. PubMed
  69. Gaitatzis A and Sander JW. The mortality of epilepsy revisited. Epileptic Disord 2004; 6: 3-13. PubMed
  70. Carmichael K, Pulman J, Lakhan SE, et al. Zonisamide add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev. 2013 ;12:CD001416. doi: 10.1002/14651858.CD001416.pub3. DOI
  71. Shi LL, Dong J, Ni H, et al. Felbamate as an add-on therapy for refractory epilepsy. Cochrane Database Syst Rev. 2014 Jul 18;7:CD008295. DOI: 10.1002/14651858.CD008295.pub3 DOI
  72. Leppik IE, Birnbaum A. Epilepsy in the elderly. Semin Neurol 2002; 22: 309 - 20. PubMed
  73. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314 - 9. NEJM
  74. Perucca E. Overtreatment in epilepsy: adverse consequences and mechanisms. Epilepsy Res 2002; 52: 25 - 33. PubMed
  75. Brodtkorb E, Bråthen G, Bovim G, Helde G. Uenighet om epilepsi og bilkjøring. Tidsskr Nor Lægeforen 2004; 124: 1100-2. Tidsskriftet

Debattregler